Dechert served as legal counsel to Aquestive Therapeutics, Inc., while Cooley acted for the underwriters on the offering.Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”),…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
